Showing results (171-180 of 262) with videos related to
Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2012
Outcome of acute promyelocytic leukemia (APL) in children and adolescents: an analysis in two consecutive trials of the European APL GroupCecile Bally, Jehane Fadlallah, Guy Leverger, et al.Blood|May 15, 2004
Randomized comparison of double induction and timed-sequential induction to a "3 + 7" induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 studySylvie Castaigne, Sylvie Chevret, Eric Archimbaud, et al.Leukemia Research|May 30, 2008
Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA groupOumedaly Reman, Arnaud Pigneux, Françoise Huguet, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 studyFrançoise Huguet, Thibaut Leguay, Emmanuel Raffoux, et al.Blood|March 8, 2007
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trialClaude Gardin, Pascal Turlure, Thierry Fagot, et al.British Journal of Haematology|February 22, 2011
l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trialCarine Domenech, Xavier Thomas, Sylvie Chabaud, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2012
Superior long-term outcome with idarubicin compared with high-dose daunorubicin in patients with acute myeloid leukemia age 50 years and olderClaude Gardin, Sylvie Chevret, Cécile Pautas, et al.Cancer|April 8, 2015
Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL groupThorsten Braun, Sophie Cereja, Sylvie Chevret, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2017
Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia StudyJonathan Bond, Carlos Graux, Ludovic Lhermitte, et al.Cancers|May 5, 2021
The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated IntensivelyMaël Heiblig, Nicolas Duployez, Alice Marceau, et al.Pageof 27